Retina Clinical Trial
Official title:
Normative Data Collection Study of the Zilia Ocular for the Measurement of Oxygen Saturation in the Retina
NCT number | NCT04408677 |
Other study ID # | ZCI01 |
Secondary ID | |
Status | Terminated |
Phase | N/A |
First received | |
Last updated | |
Start date | June 2, 2021 |
Est. completion date | September 22, 2021 |
Verified date | February 2023 |
Source | Zilia Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Mainstream oximetry devices use two-wavelength systems to photograph the retina and estimate the oxygen saturation levels in the retinal vessels by comparing light absorption in the blood of the vessels at the selected wavelengths. This method limits the measurements to large retinal vessels, depends heavily on calibration and is non-reproducible across machines. The few numbers of wavelengths used (two) also makes it very susceptible to noise (such as cataract). These shortcomings have largely limited the use of retinal oximetry in clinical practice. A new technology for retinal oximetry has recently been developed to address issues of dual-wavelength oximeters. Zilia Ocular's oximetry machine uses multi-wavelengths of light to take continuous oxygenation measurements of any targeted regions of the retina. It can measure any area of the retina, including the blood vessels, retinal tissues and the optic nerve head. Its multi-wavelength design also allows it to be less susceptible to noise, more precise and reproducible. This technology has the potential to extend our understanding of retinal pathologies, serve as a new marker for retinal health and even be used as a diagnostic tool to detect retinal injuries before they become visible. Zilia's novel technology is one of its kind, allowing continuous and accurate measurements of the retina's oxygen saturation. In order to apply this technology to study and investigate retinal diseases, we need to first examine its performance in normal eyes and build a normative database as a reference. Thus, the purpose of the current study is to build a database of baseline oximetry values in healthy Caucasian subjects. The reproducibility of the measurements will also be studied in a subset of patients.
Status | Terminated |
Enrollment | 33 |
Est. completion date | September 22, 2021 |
Est. primary completion date | September 22, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult patients above 18 years old, able to consent and willing to undergo mydriasis. - Caucasian descent. - Intraocular pressure = 21 mmHg. - Normal ophthalmological exam. Exclusion Criteria: - Any history of systemic disease, which could affect the eye or oxygen levels (eg: diabetes, severe cardiovascular or respiratory disease). - History of epilepsy. - Prior intraocular surgery (except cataract surgery). - Any history or signs of retinal or optic nerve diseases. - Pregnancy, or breastfeeding. - Familial history of glaucoma. - Ametropia > 6 Diopters. - Pupil dilation < 3.6 mm. - Current smoker. |
Country | Name | City | State |
---|---|---|---|
Canada | Hôpital du Saint-Sacrement | Québec |
Lead Sponsor | Collaborator |
---|---|
Zilia Inc. | CHU de Quebec-Universite Laval |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Normative values of the retinal oxygen saturation at different locations on the retina | Oxygen saturation measurement in the eye fundus of healthy subjects from different age groups | 12-15 months | |
Secondary | Intraclass correlation coefficient of the measurements on the same patient at the same visit | Repeatability of the eye fundus oxygen saturation measurements (same subject, same visit, same eye, same eye fundus location) | 12-15 months | |
Secondary | Percent difference between the measurements of the two eyes. | Variability of the eye fundus oxygen saturation measurements between the right and left eyes (same subject, same visit, different eye, same eye fundus location) | 12-15 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00431691 -
Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans.
|
Phase 4 | |
Completed |
NCT01157338 -
Clinical Significance of Retinal Emboli During Diagnostic and Therapeutic Cardiac Catheterization
|
N/A | |
Completed |
NCT03326908 -
Description of the Interdigitation Retinal Area by SD-OCT: An Exploratory Study
|
N/A | |
Completed |
NCT04794634 -
Relationship Between Alzheimer Disease and Diminution of the Three Macular Nervous Retinal Layers
|
N/A | |
Recruiting |
NCT05747742 -
Effect of Different Intensities of Repeated Low-Level Red-Light Therapy on Choroidal and Retinal Blood Flow Among Adults
|
N/A | |
Completed |
NCT00709423 -
Effects of Moxaverine and Placebo on Ocular Blood Flow
|
Phase 2 | |
Completed |
NCT00814008 -
The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp
|
Phase 2 | |
Completed |
NCT00706927 -
Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
|
N/A | |
Completed |
NCT00451763 -
Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia
|
Phase 3 | |
Recruiting |
NCT02614625 -
Spectral-domain Optical Coherence Tomography of the Eye
|
N/A | |
Completed |
NCT00431730 -
Is There a Difference in Flicker Induced Vasodilatation Between Smokers and Non-Smokers?
|
N/A | |
Completed |
NCT03197493 -
Extension, Carbidopa-levodopa in Neovascular AMD
|
Phase 2 | |
Not yet recruiting |
NCT05796856 -
Effect of Different Wavelengths of Repeated Low-Level Light Therapy on Choroidal and Retinal Blood Flow Among Adults
|
N/A | |
Completed |
NCT00431548 -
Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV)
|
N/A |